Not a good buy right now for an impatient entry: AMAL is technically stretched (RSI 81) and sitting right under near-term resistance (~40.42), which skews risk/reward toward a pullback.
Trend is still bullish (SMA5>SMA20>SMA200 and MACD expanding), so it’s a hold/avoid chasing rather than a bearish call.
Options positioning (high put/call open interest) leans defensive, which reduces the odds of an immediate clean breakout.
Immediate resistance: R1 = 40.424 (price is right below it); next resistance R2 = 42.051.
Key pivot/support: 37.79; then S1 = 35.156.
Pattern-based projection (similar candlesticks): modest edge near-term (+0.47% next day, +0.08% next week) but stronger 1-month tendency (+4.19%), implying upside may be slower and choppier from here.
Options Data
Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Open interest skew: Put OI 62 vs Call OI 26; Put/Call OI ratio 2.38 → defensive/bearish-leaning positioning (hedging demand).
Volume: effectively no options volume today (0), so sentiment signal is mostly from positioning, not fresh flow.
Volatility: IV30 ~64% vs historical vol ~36.9% → options imply elevated uncertainty/risk premium; not confirming an “easy” upside breakout setup.
Liquidity note: total OI ~88 contracts is small, so the options signal can be noisy.
Technical Summary
Sell
5
Buy
10
Positive Catalysts
Trading trends: hedge funds and insiders are neutral (no recent negative cluster selling indicated).
2025-11-19 (Piper Sandler): upgraded Underweight → Neutral, PT $27 → $28; rationale included underperformance creating a peer discount and reduced “debanking”/portfolio concern.
Wall Street pros vs cons (from the provided notes):
Pros: improving perception/risk framing, discount-to-peers argument, and at least one high-conviction positive (KBW Outperform + big PT raise).
Cons: still limited broad coverage and mixed stance (Neutral from Piper), with reputation/political narrative risk (debanking/ESG-related concerns) lingering in the background.
Wall Street analysts forecast AMAL stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMAL is 28 USD with a low forecast of 28 USD and a high forecast of 28 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast AMAL stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMAL is 28 USD with a low forecast of 28 USD and a high forecast of 28 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 40.230
Low
28
Averages
28
High
28
Current: 40.230
Low
28
Averages
28
High
28
Keefe Bruyette
David Konrad
maintain
$36 -> $43
AI Analysis
2026-01-26
Reason
Keefe Bruyette
David Konrad
Price Target
$36 -> $43
AI Analysis
2026-01-26
maintain
Reason
Keefe Bruyette analyst David Konrad raised the firm's price target on Amalgamated Financial to $43 from $36 and keeps an Outperform rating on the shares.
Piper Sandler
Underweight -> Neutral
upgrade
$27 -> $28
2025-11-19
Reason
Piper Sandler
Price Target
$27 -> $28
2025-11-19
upgrade
Underweight -> Neutral
Reason
Piper Sandler upgraded Amalgamated Financial to Neutral from Underweight with a price target of $28, up from $27.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for AMAL
